Yan Ling Selected Research

Yan Ling Research Topics

Disease

19	Neoplasms (Cancer) 03/2024 - 07/2003
7	Inflammation (Inflammations) 12/2023 - 02/2011
6	Tuberculosis (Tuberculoses) 07/2023 - 10/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 11/2003
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2011
4	Sepsis (Septicemia) 03/2015 - 01/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2022
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2011
3	Carcinogenesis 01/2022 - 10/2011
3	Graves Disease (Basedow Disease) 01/2022 - 01/2020
3	Pre-Eclampsia (Preeclampsia) 01/2021 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 01/2019 - 01/2017
3	Hypertriglyceridemia 05/2017 - 01/2016
3	Pancreatitis 02/2016 - 07/2008
3	Infections 02/2014 - 06/2012
3	Hyperglycemia 06/2008 - 05/2007
2	Adenocarcinoma of Lung 11/2023 - 07/2021
2	Lymphatic Metastasis 09/2023 - 12/2019
2	Papillary Thyroid Cancer 09/2023 - 01/2018
2	Disease Progression 01/2023 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
2	Critical Illness (Critically Ill) 01/2022 - 09/2012
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 03/2020 - 10/2014
2	Atherosclerosis 01/2020 - 08/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2018 - 01/2017
2	Insulin Resistance 10/2017 - 09/2011
2	Coronary Disease (Coronary Heart Disease) 10/2017 - 05/2017
2	Reperfusion Injury 04/2015 - 10/2012
2	Cognitive Dysfunction 07/2009 - 09/2007
2	Breast Neoplasms (Breast Cancer) 11/2008 - 07/2007
1	Wounds and Injuries (Trauma) 01/2023
1	Residual Neoplasm 01/2023
1	Communicable Diseases (Infectious Diseases) 11/2022
1	Cardiotoxicity 10/2022
1	Body Weight (Weight, Body) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2003
6	HMGB1 Protein (HMG1)IBA 01/2018 - 07/2008
6	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 08/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2019
3	phosphopantetheinyl transferaseIBA 03/2024 - 10/2022
3	EnzymesIBA 07/2023 - 10/2007
3	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2020
3	LipidsIBA 10/2022 - 04/2011
3	ApolipoproteinsIBA 01/2020 - 09/2007
3	oxidized low density lipoproteinIBA 01/2019 - 04/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 07/2013
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 05/2011
3	Small Interfering RNA (siRNA)IBA 04/2015 - 08/2011
3	Insulin-Like Growth Factor I (IGF-1)IBA 06/2008 - 05/2007
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 11/2023 - 01/2022
2	Thyroid HormonesIBA 09/2023 - 01/2017
2	LactamsIBA 11/2022 - 01/2020
2	AlbuminsIBA 01/2022 - 05/2018
2	neurotoxic esteraseIBA 01/2021 - 01/2018
2	alectinibIBA 01/2021 - 01/2021
2	AldosteroneIBA 01/2020 - 09/2011
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2017
2	Apolipoproteins E (ApoE)IBA 01/2020 - 09/2007
2	HDL CholesterolIBA 01/2019 - 05/2017
2	CytokinesIBA 01/2018 - 01/2015
2	Natalizumab (Tysabri)FDA Link 12/2017 - 06/2017
2	aducanumabIBA 01/2017 - 01/2016
2	Apolipoprotein C-II (ApoC2)IBA 02/2016 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 11/2003
2	LigandsIBA 10/2014 - 08/2007
2	Uric Acid (Urate)IBA 11/2013 - 02/2012
1	Thymidylate SynthaseIBA 03/2024
1	raltitrexed (D 1694)IBA 03/2024
1	NF-kappa B (NF-kB)IBA 12/2023
1	Oxidants (Oxidizing Agents)IBA 12/2023
1	AntioxidantsIBA 12/2023
1	osimertinibIBA 11/2023
1	Gefitinib (Iressa)FDA Link 11/2023
1	N-methyladenosineIBA 10/2023
1	Epithelial Cell Adhesion MoleculeIBA 10/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	NanogelsIBA 01/2023
1	CollagenIBA 01/2023
1	anlotinibIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	HydrogelsIBA 01/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2022
1	Ion Channels (Ion Channel)IBA 10/2022
1	benzamideIBA 10/2022
1	Virulence Factors (Pathogenicity Factors)IBA 10/2022
1	tanezumabIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021

Therapy/Procedure

13	Therapeutics 04/2024 - 05/2005
4	Immunotherapy 04/2024 - 03/2020
4	Drug Therapy (Chemotherapy) 01/2022 - 10/2007
1	Aftercare (After-Treatment) 11/2023